Table of Contents
Journal of Cancer Research
Volume 2016, Article ID 4743075, 7 pages
Research Article

Factors Affecting the Practices of Cervical Cancer Screening among Female Nurses at Public Health Institutions in Mekelle Town, Northern Ethiopia, 2014: A Cross-Sectional Study

1Dr. Tewelde Legesse Health Science College, Godena Musse, P.O. Box 306, Mekelle, Ethiopia
2Department of Nursing, Mekelle University, Ayder Kifle Ketema, P.O. Box 1871, Mekelle, Ethiopia

Received 30 November 2015; Revised 24 January 2016; Accepted 3 February 2016

Academic Editor: Hugo Arias-Pulido

Copyright © 2016 Mihret Gebreegziabher et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Objective. In Ethiopia, the age-adjusted incidence rate of cervical cancer is high, 35.9 per 100,000 women. Despite this fact, cervical cancer screening coverage in Ethiopia is very low. The objective of this study is to assess the magnitude and factors affecting the practices of cervical cancer screening among female nurse in Mekelle Town, Tigray, Northern Ethiopia, 2014. Methods. This study used a cross-sectional design. Bivariate and multivariate logistic regression was used to evaluate factors associated with cervical cancer screening practice. Results. A total of 225 female nurses participated in the study. The magnitude of cervical cancer screening practice among these nurses was 10.7%, within the past five years of the survey. Attitude and work place of the respondents were significantly associated with a history of cervical cancer screening practices with an adjusted odds ratio (AOR) of 3.023, 95% CI (1.134–8.059), and 3.424, 95% CI (1.080–10.853), respectively. Conclusion. The study showed that the magnitude of the cervical screening practice is very low among nurse health professionals. Negative attitude and workplace were identified to be the predictors of decision for cervical cancer test.